Authors:
Winterer, G
Egan, MF
Radler, T
Hyde, T
Coppola, R
Weinberger, DR
Citation: G. Winterer et al., An association between reduced interhemispheric EEG coherence in the temporal lobe and genetic risk for schizophrenia (vol 49, pg 129, 2001), SCHIZOPHR R, 51(2-3), 2001, pp. 181-181
Authors:
Winterer, G
Egan, MF
Radler, T
Hyde, T
Coppola, R
Weinberger, DR
Citation: G. Winterer et al., An association between reduced interhemispheric EEG coherence in the temporal lobe and genetic risk for schizophrenia, SCHIZOPHR R, 49(1-2), 2001, pp. 129-143
Authors:
Dawson, NM
Hamid, EH
Egan, MF
Meredith, GE
Citation: Nm. Dawson et al., Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment, SYNAPSE, 39(1), 2001, pp. 70-81
Authors:
Egan, MF
Goldberg, TE
Kolachana, BS
Callicott, JH
Mazzanti, CM
Straub, RE
Goldman, D
Weinberger, DR
Citation: Mf. Egan et al., Effect of COMT Val(108/158) Met genotype on frontal lobe function and riskfor schizophrenia, P NAS US, 98(12), 2001, pp. 6917-6922
Authors:
Bertolino, A
Callicott, JH
Mattay, VS
Weidenhammer, KM
Rakow, R
Egan, MF
Weinberger, DR
Citation: A. Bertolino et al., The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia, BIOL PSYCHI, 49(1), 2001, pp. 39-46
Authors:
Meyer-Lindenberg, A
Poline, JB
Kohn, PD
Holt, JL
Egan, MF
Weinberger, DR
Berman, KF
Citation: A. Meyer-lindenberg et al., Evidence for abnormal cortical functional connectivity during working memory in schizophrenia, AM J PSYCHI, 158(11), 2001, pp. 1809-1817
Authors:
Bower, CM
Hyde, TM
Zaka, M
Hamid, EH
Baca, SM
Egan, MF
Citation: Cm. Bower et al., Decreased mu-opioid receptor binding in the globus pallidus of rats treated with chronic haloperidol, PSYCHOPHAR, 150(3), 2000, pp. 260-263
Citation: Ja. Apud et al., Effects of smoking during antipsychotic withdrawal in patients with chronic schizophrenia, SCHIZOPHR R, 46(2-3), 2000, pp. 119-127
Authors:
Raedler, TJ
Knable, MB
Jones, DW
Lafargue, T
Urbina, RA
Egan, MF
Pickar, D
Weinberger, DR
Citation: Tj. Raedler et al., In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia, NEUROPSYCH, 23(1), 2000, pp. 56-68
Authors:
Meredith, GE
De Souza, IEJ
Hyde, TM
Tipper, G
Wong, ML
Egan, MF
Citation: Ge. Meredith et al., Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias, J NEUROSC, 20(20), 2000, pp. 7798-7806
Authors:
Goldberg, TE
Dodge, M
Aloia, M
Egan, MF
Weinberger, DR
Citation: Te. Goldberg et al., Effects of neuroleptic medications on speech disorganization in schizophrenia: biasing associative networks towards meaning, PSYCHOL MED, 30(5), 2000, pp. 1123-1130
Authors:
Weickert, TW
Goldberg, TE
Gold, JM
Bigelow, LB
Egan, MF
Weinberger, DR
Citation: Tw. Weickert et al., Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect, ARCH G PSYC, 57(9), 2000, pp. 907-913
Authors:
Callicott, JH
Bertolino, A
Egan, MF
Mattay, VS
Langheim, FJP
Weinberger, DR
Citation: Jh. Callicott et al., Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia, AM J PSYCHI, 157(10), 2000, pp. 1646-1651
Authors:
Raedler, TJ
Knable, MB
Lafargue, T
Urbina, RA
Egan, MF
Pickar, D
Weinberger, DR
Citation: Tj. Raedler et al., In vivo determination of striatal dopamine D-2 receptor occupancy in patients treated with olanzapine, PSYCH RES-N, 90(2), 1999, pp. 81-90
Authors:
Callicott, JH
Egan, MF
Bertlino, A
Mattay, VS
Langheim, FJP
Frank, JA
Weinberger, DR
Citation: Jh. Callicott et al., Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: A possible intermediate neurobiological (vol 44, pg 941, 1998), BIOL PSYCHI, 45(2), 1999, pp. 245-245